OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
1.700
+0.010 (0.59%)
At close: Feb 13, 2026, 4:00 PM EST
1.760
+0.060 (3.53%)
After-hours: Feb 13, 2026, 7:26 PM EST
OmniAb Market Cap
OmniAb has a market cap or net worth of $244.72 million as of February 13, 2026. Its market cap has decreased by -37.00% in one year.
Market Cap
244.72M
Enterprise Value
206.29M
1-Year Change
-37.00%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $244.72M, a decrease of -75.35%. That is a compound annual growth rate of -34.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 244.72M | -8.11% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 263.33M |
| Enlivex Therapeutics | 261.12M |
| Palisade Bio | 259.27M |
| Sutro Biopharma | 255.98M |
| Climb Bio | 251.61M |
| Shattuck Labs | 247.42M |
| Coherus Oncology | 242.95M |
| Opus Genetics | 233.79M |